News

The most common conditions or concerns patients reported having that may influence their selection of a JAK inhibitor included an increased risk of MACE and an age above 65 years.

Re-treatment 12 months after initial hyaluronic acid filler treatment resulted in further infraorbital rejuvenation.

Mast spoke with Dermatology Times about her conference workshop, what she's looking forward to ahead of this week's SDPA conference, and the importance of always maintaining a passion for patients.

When sessions, late-breaking research, and more conclude at SDPA Fall 2023, there is no shortage of things to do in Nashville.

Preposterous opinions are not considered perjury. Fictional factual claims may be actionable as perjury.

It is important to know about any and all fees one is being charged because the transparency of the fee is a sign of an ethical business model.

Click here to answer today's poll.

The conference aimed at providing dermatology physician assistants with the latest in the field begins tomorrow in Nashville, Tennessee.

Little is known about the ways primary care physicians should treat or manage atopic dermatitis in their patients, according to the review.

Black and male patients exhibited a higher prevalence of palmoplantar psoriasis when compared with White patients.

BoNT/E represents a novel approach in the world of neurotoxins, characterized by its rapid onset of action.

Helen Torok, MD, shares her atopic dermatitis insights.

The study encompassed an impressive 151 publications, comprising 110 studies and a total of 10,187 patients.

Pharmacists play a role in advising patients with hair loss about self-management and proper application of over the counter products.

Four grants were awarded for communities in communities in Miami-Dade County, Florida; Los Angeles County, California; rural communities in Oregon, and downtown Philadelphia, Pennsylvania.

A recent study found that in Europe, approximately 1 in 5 individuals with chronic skin disease felt that they were looked at by others with disgust.

Prepare your patients with helpful resources during National Eczema Awareness Month.

If you weren’t able to attend the 2023 Fall Clinical Dermatology Conference or want to review our latest coverage and interviews, our full recap has you covered.

Catch up on coverage from the final day of the 2023 Fall Clinical Dermatology Conference.

This study aimed to evaluate the association between the disease burden of psoriasis and the switching of systemic biologic therapies in patients with both psoriasis and psoriatic arthritis.

There is a lot of conversation drumming around the boxed warnings for newer JAK inhibitors, and fact versus fiction was discussed at Fall Clinical.

Susan Taylor, MD, walked Fall Clinical attendees through an in-depth hyperpigmentation session that included melasma and its mimickers.

Kirby presented at both Fall Clinical and the Inflammatory Disease Summit in Las Vegas.

Sandra Lee, MD, and other top acne experts took the stage to debate cases and treatments.

Primary and secondary melanoma prevention factors are necessary to reduce patients’ melanoma risk.

Renata Block, MMS, PA-C, shares her atopic dermatitis insights.

The latest CDC data shows an uptick in syphilis, which can lead to a rare form of alopecia or a presentation of psoriasis.

Catch up on coverage from the third day of the 2023 Fall Clinical Dermatology Conference.

Although still in its early stages, the program showcases the potential value of tangible interactions between dedicated navigators and patients in enhancing support and continuity of care.

Keep up with the latest headlines in dermatology from the past week, including the creation of a dermatology outreach organization centered in Detroit, a tropical skin disease endemic in parts of the US, and more.